Table 1.
Clinical and demographic features of IgAN patients and healthy controls.
| Feature | pDC | IFN-alpha | ||
|---|---|---|---|---|
| Healthy controls | IgAN patients | Healthy controls | IgAN patients | |
| Gender (male/female) | 12/21 | 11/21 | 10/22 | 9/25 |
| Age (yr) | 33.6 ± 9.3 | 32.5 ± 9.7 | 35.8 ± 9.6 | 31.7 ± 9.3 |
| Serum creatinine (μM) | 81.3 ± 32.8 | 69 ± 24 | ||
| 24-hour proteinuria (g/24 h) | 1.00 ± 0.78 | 0.74 ± 0.48 | ||
| eGFR | 98.5 ± 29.1 | 108.4 ± 23.9 | ||